(Q37988746)

26 August 2017

title

Growth/differentiation factor-15: prostate cancer suppressor or promoter? (English)

1 reference

26 August 2017

1 reference

P Vaňhara

1

1 reference

26 August 2017

A Hampl

series ordinal

2

1 reference

26 August 2017

A Kozubík

series ordinal

3

1 reference

26 August 2017

K Souček

series ordinal

4

1 reference

26 August 2017

publication date

28 February 2012

1 reference

Prostate Cancer and Prostatic Diseases

26 August 2017

published in

1 reference

26 August 2017

volume

15

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

320-328

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2012.6

26 August 2017

exact match

0 references

cites work

Cytokines in cancer pathogenesis and cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

PLAB, a novel placental bone morphogenetic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Human cDNA encoding a novel TGF-beta superfamily protein highly expressed in placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Macrophage Inhibitory Cytokine-1 H6D Polymorphism, Prostate Cancer Risk, and Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: effects on secretion and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Cleavage of growth differentiation factor 15 (GDF15) by membrane type 1-matrix metalloproteinase abrogates GDF15-mediated suppression of tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Growth-differentiation factor-15 in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

GDF15 triggers homeostatic proliferation of acid-secreting collecting duct cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Progressive postnatal motoneuron loss in mice lacking GDF-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Regulation of GDF-15, a distant TGF-β superfamily member, in a mouse model of cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Maternal serum and amniotic fluid levels of macrophage inhibitory cytokine 1 in Down syndrome and chromosomally normal pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Growth/differentiation factor-15 is an abundant cytokine in human seminal plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Weight loss in patients with advanced cancer: effects, causes, and potential management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Adipocyte culture medium stimulates production of macrophage inhibitory cytokine 1 in MDA-MB-231 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3beta, C/EBPbeta and ATF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

A novel anticancer effect of Astragalus saponins: Transcriptional activation of NSAID-activated gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Macrophage inhibitory cytokine-1 regulates melanoma vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

GDF-15 contributes to proliferation and immune escape of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Influence of inflammation and aging on macrophage inhibitory cytokine-1 gene expression in rat ventral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Association of prostatic inflammation with down-regulation of macrophage inhibitory cytokine-1 gene in symptomatic benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Dynamics of expression of growth differentiation factor 15 in normal and PIN development in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

MIC1 and IL1RN genetic variation and advanced prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Docetaxel-based combination therapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Dysregulated expression of MIC-1/PDF in human prostate tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of osteoclast differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

NSAID inhibition of prostate cancer cell migration is mediated by Nag-1 Induction via the p38 MAPK-p75(NTR) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Antibody-based approach to high-volume genotyping for MIC-1 polymorphism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Growth differentiation factor 15 in different stages of heart failure: potential screening implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Growth-differentiation factor-15: a novel biomarker in patients with diastolic dysfunction?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

GDF-15 promotes angiogenesis through modulating p53/HIF-1α signaling pathway in hypoxic human umbilical vein endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Macrophage Inhibitory Cytokine-1 in Gestational Tissues and Maternal Serum in Normal and Pre-eclamptic Pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

A novel p53 transcriptional repressor element (p53TRE) and the asymmetrical contribution of two p53 binding sites modulate the response of the placental transforming growth factor-beta promoter to p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

The H6D variant of NAG-1/GDF15 inhibits prostate xenograft growth in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.6

31 March 2020

Identifiers

DOI

10.1038/PCAN.2012.6

1 reference

Dimensions Publication ID

26 August 2017

1003938111

0 references

1 reference